: Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of disorders in which chronic inflammation of the skeletal muscle, leading to muscle weakness, is a common feature. Different phenotypes have been identified within the IIM spectrum based on extra-muscular manifestations, immunology, muscle histology, responsiveness to therapy, and prognosis. The pathogenesis, classification, treatment, and prognosis of the different IIM subtypes are subject to active discussion and research. This review highlights the most relevant literature published on this topic over the last year.
Dourado, E., Bottazzi, F., Cardelli, C., Conticini, E., Schmidt, J., Cavagna, L., et al. (2023). Idiopathic inflammatory myopathies: one year in review 2022. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 41(2), 199-213 [10.55563/clinexprheumatol/jof6qn].
Idiopathic inflammatory myopathies: one year in review 2022
Cardelli, Chiara;Conticini, Edoardo;
2023-01-01
Abstract
: Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of disorders in which chronic inflammation of the skeletal muscle, leading to muscle weakness, is a common feature. Different phenotypes have been identified within the IIM spectrum based on extra-muscular manifestations, immunology, muscle histology, responsiveness to therapy, and prognosis. The pathogenesis, classification, treatment, and prognosis of the different IIM subtypes are subject to active discussion and research. This review highlights the most relevant literature published on this topic over the last year.File | Dimensione | Formato | |
---|---|---|---|
Idiopathic inflammatory myopathies-Conticini-2023.pdf
non disponibili
Descrizione: Free full-text sul sito dell'editore
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
517.05 kB
Formato
Adobe PDF
|
517.05 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1263474